{
    "clinical_study": {
        "@rank": "120861", 
        "arm_group": [
            {
                "arm_group_label": "Olodaterol and Tiotropium", 
                "arm_group_type": "Experimental", 
                "description": "2 puffs olodaterol from Respimat  and one capsule tiotropium from Handihaler once daily in am, co-administered"
            }, 
            {
                "arm_group_label": "Placebo and Tiotropium", 
                "arm_group_type": "Other", 
                "description": "2 puffs placebo inhalation solution from Respimat and one capsule tiotropium from Handihaler once daily in am, co-administered"
            }
        ], 
        "brief_summary": {
            "textblock": "The overall objective of this study is to assess efficacy and safety of 12 weeks, once\n      daily, orally inhaled co-administration of olodaterol 5 \u00b5g (delivered by the Respimat\u00ae\n      Inhaler) and tiotropium (delivered by the Handihaler\u00ae as Spiriva Handihaler\u00ae), compared to\n      tiotropium (Spiriva Handihaler\u00ae) monotherapy on lung function in patients with COPD."
        }, 
        "brief_title": "Co-administration of Olodaterol Respimat\u00ae and Tiotropium Handihaler\u00ae", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pulmonary Disease, Chronic Obstructive", 
        "condition_browse": {
            "mesh_term": [
                "Chronic Disease", 
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          1. All patients must sign an informed consent consistent with International Conference\n             on Harmonization-Good Clinical Practice (ICH-GCP) guidelines prior to participation\n             in the trial, which includes medication washout and restrictions.\n\n          2. All patients must have a diagnosis of chronic obstructive pulmonary disease and must\n             meet the following spirometric criteria: Patients must have a relatively stable\n             airway obstruction with a post-bronchodilator FEV1  = 30 % and < 80% of predicted\n             normal and a post-bronchodilator FEV1/FVC <70% at Visit 1.\n\n          3. Male or female patients, 40 years of age or older.\n\n          4. Patients must be current or ex-smokers with a smoking history of more than 10 pack\n             years\n\n          5. Patients must be able to: perform technically acceptable pulmonary function tests,\n             and maintain records(paper diary).\n\n          6. Patients must be able to inhale medication in a competent manner from the Respimat\n             Inhaler as well as the Handihaler.\n\n        Exclusion criteria:\n\n          1. Patients with a significant disease other than COPD; a significant disease is defined\n             as a disease which, in the opinion of the investigator, may (i) put the patient at\n             risk because of participation in the study, (ii) influence the results of the study,\n             or (iii) cause concern regarding the patients ability to participate in the study.\n\n          2. Patients with clinically relevant abnormal baseline haematology, blood chemistry, or\n             urinalysis; all patients with an AST >x2 ULN, ALT >x2 ULN, bilirubin >x2 ULN or\n             creatinine >x2 ULN will be excluded regardless of clinical condition (a repeat\n             laboratory evaluation will not be conducted in these patients).\n\n          3. Patients with a history of asthma. For patients with allergic rhinitis or atopy,\n             source documentation is required to verify that the patient does not have asthma. If\n             a patient has a total blood eosinophil count =600/mm3, source documentation is\n             required to verify that the increased eosinophil count is related to a non-asthmatic\n             condition.\n\n          4. A diagnosis of thyrotoxicosis (due to the known class side effect profile of\n             \u00df2-agonists).\n\n          5. A diagnosis of paroxysmal tachycardia (>100 beats per minute) (due to the known class\n             side effect profile of \u00df2-agonists).\n\n          6. A history of myocardial infarction within 1 year of screening visit (Visit 1).\n\n          7. Unstable or life-threatening cardiac arrhythmia.\n\n          8. Hospitalization for heart failure within the past year.\n\n          9. Known active tuberculosis.\n\n         10. A malignancy for which patient has undergone resection, radiation therapy or\n             chemotherapy within last five years (patients with treated basal cell carcinoma are\n             allowed).\n\n         11. A history of life-threatening pulmonary obstruction.\n\n         12. A history of cystic fibrosis.\n\n         13. Clinically evident bronchiectasis.\n\n         14. A history of significant alcohol or drug abuse.\n\n         15. Patients who have undergone thoracotomy with pulmonary resection (patients with a\n             history of thoracotomy for other reasons should be evaluated as per exclusion\n             criterion No. 1).\n\n         16. Patients being treated with oral or patch \u00df-adrenergics.\n\n         17. Patients being treated with oral corticosteroid medication at unstable doses (i.e.,\n             less than six weeks on a stable dose) or at doses in excess of the equivalent of 10\n             mg of prednisone per day or 20 mg every other day.\n\n         18. Patients who regularly use daytime oxygen therapy for more than one hour per day and\n             in the investigators opinion will be unable to abstain from the use of oxygen therapy\n             during clinic visits.\n\n         19. Patients who have completed a pulmonary rehabilitation program in the six weeks prior\n             to the screening visit (Visit 1) or patients who are currently in a pulmonary\n             rehabilitation program.\n\n         20. Patients who have taken an investigational drug within one month or six half lives\n             (whichever is greater) prior to screening visit (Visit 1).\n\n         21. Patients with known hypersensitivity to \u00df-adrenergic drugs, BAC, EDTA, or any other\n             component of the Respimat\u00ae inhalation solution.\n\n         22. Patients with known hypersensitivity to anticholinergic drugs, lactose, or any other\n             components of the HandiHaler\u00ae.\n\n         23. Pregnant or nursing women.\n\n         24. Women of childbearing potential not using a highly effective method of birth\n             control*. Female patients will be considered to be of childbearing potential unless\n             surgically sterilised by hysterectomy or bilateral tubal ligation, or post-menopausal\n             for at least two years.\n\n             * as per ICH M3(R2) a highly effective method of birth control is defined as those\n             which result in a low failure rate (i.e. less than 1% per year).\n\n         25. Patients who have previously been randomised in this study or are currently\n             participating in another study.\n\n         26. Patients who are unable to comply with pulmonary medication restrictions prior to\n             randomisation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "1134", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01694771", 
            "org_study_id": "1222.51"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo and Tiotropium", 
                "description": "Marketed dose", 
                "intervention_name": "Tiotropium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo and Tiotropium", 
                "description": "One dose", 
                "intervention_name": "Placebo matching Olodaterol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Olodaterol and Tiotropium", 
                "description": "One dose", 
                "intervention_name": "Olodaterol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Olodaterol and Tiotropium", 
                "description": "Marketed dose", 
                "intervention_name": "Tiotropium", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tiotropium"
        }, 
        "lastchanged_date": "January 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Florence", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "1222.51.01055 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jasper", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "1222.51.01087 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "1222.51.01066 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "1222.51.01069 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.51.01040 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Encinitas", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.51.01064 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fullerton", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.51.01060 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lincoln", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.51.01084 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.51.01041 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.51.01094 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.51.01015 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boulder", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "1222.51.01052 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wheat Ridge", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "1222.51.01010 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wheat Ridge", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "1222.51.01042 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stamford", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }, 
                    "name": "1222.51.01070 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clearwater", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01006 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clearwater", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01021 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clearwater", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01082 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "DeLand", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01065 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01051 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01092 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ormond Beach", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01081 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Panama City", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01054 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pensacola", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01062 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Orange", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01088 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tamarac", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.51.01079 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "1222.51.01075 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austell", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "1222.51.01076 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duluth", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "1222.51.01057 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lawrenceville", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "1222.51.01086 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Coeur d'Alene", 
                        "country": "United States", 
                        "state": "Idaho"
                    }, 
                    "name": "1222.51.01019 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eagle", 
                        "country": "United States", 
                        "state": "Idaho"
                    }, 
                    "name": "1222.51.01027 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Arlingron Heights", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "1222.51.01048 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "River Forest", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "1222.51.01044 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Skokie", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "1222.51.01043 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky"
                    }, 
                    "name": "1222.51.01090 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lafayette", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "1222.51.01023 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Opelousas", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "1222.51.01071 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Dartmouth", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "1222.51.01050 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "1222.51.01049 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Livonia", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "1222.51.01025 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edina", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "1222.51.01078 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fridley", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "1222.51.01033 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Charles", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "1222.51.01074 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "1222.51.01037 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reno", 
                        "country": "United States", 
                        "state": "Nevada"
                    }, 
                    "name": "1222.51.01039 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Larchmont", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "1222.51.01045 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "1222.51.01018 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Asheville", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.51.01014 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.51.01077 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greensboro", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.51.01056 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Canton", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.51.01032 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.51.01011 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.51.01005 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.51.01093 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sylvania", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.51.01089 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toledo", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.51.01080 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }, 
                    "name": "1222.51.01017 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tulsa", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }, 
                    "name": "1222.51.01047 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Corvallis", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "1222.51.01031 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medford", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "1222.51.01020 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "1222.51.01053 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Erie", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "1222.51.01016 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "1222.51.01004 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Providence", 
                        "country": "United States", 
                        "state": "Rhode Island"
                    }, 
                    "name": "1222.51.01030 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johnston", 
                        "country": "United States", 
                        "state": "Rhode Island"
                    }, 
                    "name": "1222.51.01009 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01036 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01061 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Easley", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01046 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Easley", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01038 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gaffney", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01022 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01063 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greer", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01013 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spartanburg", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01024 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Union", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.51.01012 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rapid City", 
                        "country": "United States", 
                        "state": "South Dakota"
                    }, 
                    "name": "1222.51.01008 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johnson City", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "1222.51.01035 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boerne", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.51.01028 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Corsicana", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.51.01083 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Killeen", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.51.01085 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Longview", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.51.01073 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.51.01003 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Murray", 
                        "country": "United States", 
                        "state": "Utah"
                    }, 
                    "name": "1222.51.01058 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Abingdon", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "1222.51.01068 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "1222.51.01029 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "1222.51.01034 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "1222.51.01072 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "1222.51.01091 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "1222.51.01002 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Morgantown", 
                        "country": "United States", 
                        "state": "West Virginia"
                    }, 
                    "name": "1222.51.01001 Boehringer Ingelheim Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomised, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of 12 Weeks of Once Daily, Orally Inhaled, Co-administration of Olodaterol 5\u00b5g (Delivered by the Respimat\u00ae Inhaler) and Tiotropium 18\u00b5g (Delivered by the HandiHaler\u00ae) Compared to Once Daily, Orally Inhaled, Co-administration of Placebo (Delivered by the Respimat\u00ae Inhaler) and Tiotropium 18\u00b5g (Delivered by the HandiHaler\u00ae) in Patients With Chronic Obstructive Pulmonary Disease (COPD)[ANHELTO TM 1]", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "FEV1 AUC0-3h response at 12 weeks; defined as change from baseline to Week 12", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Trough FEV1 response at 12 weeks; defined as change from baseline to Week 12", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01694771"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Saint George Respiratory Questionnaire-Total Score-  Key secondary endpoint", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Peak FEV1 response at Week - defined as change from baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "FVC AUC0-3h response at 12 - defined as change from baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Trough FVC response at 12 weeks- defined as change from baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Peak FVC response at 12 weeks- defined as change from baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Rescue medication usage - two variables will be calculated for each patient;  the number of rescue free days, and weekly mean use of rescue medications.", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}